ILC Therapeutics
Chris is chairman of the board at Proveca Ltd, Bioscript Ltd and Peakdata AG. He is a non-executive director of Optibiotox Plc and ILC Therapeutics Ltd and a partner at EOS LLC. He has extensive non-executive board experience serving on public, private and charity boards in Life Sciences and other sectors following a 30-year executive career with AstraZeneca.
Chris was appointed a CBE in January 2015 for services to Life Science.
This person is not in the org chart
This person is not in any offices
ILC Therapeutics
ILC Therapeutics is an early-stage biotechnology company focused on modulating the Innate Immune System.